1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology in Europe

Biotechnology in Europe

  • January 2016
  • -
  • MarketLine
  • -
  • 35 pages

Introduction

Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Europe biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The European biotechnology market is expected to generate total revenues of $73.8bn in 2015, representing a compound annual growth rate (CAGR) of 6% between 2011 and 2015.

- The medical/healthcare segment is expected to be the market's most lucrative in 2015, with total revenues of $47.5bn, equivalent to 64.4% of the market's overall value.

- Attracting investment is a key priority in the UK market in order to allow start-up ventures to succeed. The atmosphere for investment is not as strong as in the US where many specialist investors operate but signs are still good for the market. Nevertheless, the volatile nature of the industry ensures that future growth is by no means guaranteed.

Features

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe

- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts

- Macroeconomic indicators provide insight into general trends within the Europe economy

Key Questions Answered

- What was the size of the Europe biotechnology market by value in 2015?

- What will be the size of the Europe biotechnology market in 2020?

- What factors are affecting the strength of competition in the Europe biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Europe's biotechnology market?

Table Of Contents

Biotechnology in Europe
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 9
Market value 9
Market Segmentation 10
Category segmentation 10
Geography segmentation 11
Market Outlook 12
Market value forecast 12
Five Forces Analysis 13
Summary 13
Buyer power 14
Supplier power 15
New entrants 16
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
AstraZeneca PLC 20
Boehringer Ingelheim GmbH 23
Merck and Co., Inc. 26
F. Hoffmann-La Roche Ltd 29
Methodology 32
Industry associations 33
Related MarketLine research 33
Appendix 34
About MarketLine 34

List of Tables
Table 1: Europe biotechnology industry value: $ billion, 2011-15(e)
Table 2: Europe biotechnology industry category segmentation: $ billion, 2015(e)
Table 3: Europe biotechnology industry geography segmentation: $ billion, 2015(e)
Table 4: Europe biotechnology industry value forecast: $ billion, 2015-20
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: Boehringer Ingelheim GmbH: key facts
Table 9: Boehringer Ingelheim GmbH: key financials ($)
Table 10: Boehringer Ingelheim GmbH: key financials (€)
Table 11: Boehringer Ingelheim GmbH: key financial ratios
Table 12: Merck and Co., Inc.: key facts
Table 13: Merck and Co., Inc.: key financials ($)
Table 14: Merck and Co., Inc.: key financial ratios
Table 15: F. Hoffmann-La Roche Ltd: key facts
Table 16: F. Hoffmann-La Roche Ltd: key financials ($)
Table 17: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 18: F. Hoffmann-La Roche Ltd: key financial ratios

List of Figures
Figure 1: Europe biotechnology industry value: $ billion, 2011-15(e)
Figure 2: Europe biotechnology industry category segmentation: % share, by value, 2015(e)
Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2015(e)
Figure 4: Europe biotechnology industry value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the biotechnology industry in Europe, 2015
Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2015
Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2015
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2015
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2015
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2015
Figure 11: AstraZeneca PLC: revenues and profitability
Figure 12: AstraZeneca PLC: assets and liabilities
Figure 13: Boehringer Ingelheim GmbH: revenues and profitability
Figure 14: Boehringer Ingelheim GmbH: assets and liabilities
Figure 15: Merck and Co., Inc.: revenues and profitability
Figure 16: Merck and Co., Inc.: assets and liabilities
Figure 17: F. Hoffmann-La Roche Ltd: revenues and profitability
Figure 18: F. Hoffmann-La Roche Ltd: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global 3D cell culture market size is expected to reach USD 1345.2 million by 2021 from USD 466.8 million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is segmented based on technology, ...

Cell Expansion Market by Product , Cell Type , Application , End user  - Global Forecasts to 2021

Cell Expansion Market by Product , Cell Type , Application , End user - Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, ...

Sample Preparation Market by Product , Consumables ), Application , End Users  - Global Forecast to 2021

Sample Preparation Market by Product , Consumables ), Application , End Users - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The sample preparation market is poised to reach USD 7,203.2 million by 2021 from USD 5,512.2 in 2016, growing at a CAGR of 5.5% during the forecast period of 2016 to 2021. Sample preparation involves ...

Trends In Gene Therapy

July 2016 $ 5 000

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.